Search results
AbbVie announces LEVEL UP results in atopic dermatitis study By Investing.com
Investing.com· 2 weeks agoThe study focused on adult and adolescent patients who had an inadequate response to systemic...
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...
Investing.com· 2 weeks agoAbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study